COVID CLOT SHOTS can cause deadly SWELLING of the BRAIN according to doctor’s testimony in medical journal JAMA Neurology

Growing concerns over severe neurological reactions to Covid-19 vaccines have intensified following reports of life-threatening brain inflammation linked to AstraZeneca’s jab. In France, a previously healthy 60-year-old man developed meningoencephalitis — a dangerous swelling of the brain and spinal cord — just four weeks after receiving his first dose, leaving him with lasting neurological damage despite intensive treatment.

His case, detailed in JAMA Neurology, adds to mounting evidence of rare but devastating complications, including rare blood clots and post-vaccine encephalitis, that have prompted legal action, regulatory restrictions, and calls for better compensation for victims. While officials maintain that the vaccine’s benefits outweigh risks, emerging reports of “post-vaccination syndrome” and unresolved injuries continue to fuel global debate over vaccine safety.

• Rare but severe reactions linked to AstraZeneca vaccine – The MHRA confirmed 30 cases of rare blood clots tied to the AstraZeneca COVID-19 vaccine, with experts warning the actual number may be higher. Some patients, like a UK man who lost sensation in his legs, suffered severe neurological damage after inoculation, while others died or were left permanently disabled.
• Post-vaccine brain inflammation case study – A 60-year-old French man developed life-threatening meningoencephalitis (brain and spinal cord swelling) four weeks after receiving AstraZeneca’s vaccine. Doctors diagnosed him with post-vaccinal encephalitis, likely caused by an immune overreaction, requiring six months of immunosuppressant drugs. While he mostly recovered, lingering attention deficits persisted three years later.
• AstraZeneca restrictions and compensation challenges – Due to rare clotting risks (VITT/TSS), European nations restricted the vaccine in 2021, with the UK limiting it to older adults. At least 81 Brits died from complications, and 293 vaccine injury claims were approved—but strict criteria (e.g., 60% disability) block many from receiving £120,000 compensation.
• Emerging concerns over post-vaccination syndromes – Beyond AstraZeneca, mRNA vaccines (Pfizer/Moderna) are linked to “post-vaccination syndrome,” with symptoms like brain fog, tinnitus, and immune abnormalities. Researchers also warn of reactivated Epstein-Barr virus in some cases, though findings remain preliminary.

Rare but deadly brain swelling linked to AstraZeneca COVID Vaccine in new case study

A 60-year-old man’s near-fatal reaction renews scrutiny on vaccine risks and long-term monitoring. A healthy 60-year-old man in France developed life-threatening brain inflammation just weeks after receiving the AstraZeneca COVID-19 vaccine, according to a case study published in JAMA Neurology. Four weeks post-vaccination, the unnamed patient experienced sudden walking difficulties and mental confusion, prompting doctors to diagnose meningoencephalitis—a dangerous swelling of the brain and spinal cord.

Despite no evidence of infections or underlying diseases, medical experts concluded his immune system overreacted to the vaccine, leading to a rare but severe neurological complication. His case, alongside mounting reports of similar incidents, raises urgent questions about vaccine safety mechanisms and long-term patient monitoring.

The patient initially improved after emergency treatment but relapsed three months later, requiring six months of immunosuppressive drugs to control the inflammation. Though he nearly recovered after three years, lingering attention deficits remained. Doctors emphasized the need for “prompt diagnosis and aggressive treatment” in such cases, given the unpredictability of post-vaccine neurological reactions.

A 2023 study of 65 encephalitis patients linked AstraZeneca’s vaccine to over a third of cases, though most recovered fully. The precise trigger remains unknown, highlighting gaps in understanding how vaccines interact with individual immune systems.

France and other European nations restricted AstraZeneca’s vaccine in early 2021 after reports of rare blood clots, known as thrombosis with thrombocytopenia syndrome (TTS). At least 81 UK deaths were tied to the complication, prompting age-based rollback policies. Despite these risks, the vaccine is credited with saving 6 million lives globally during the pandemic.

Meanwhile, compensation for vaccine injuries remains contentious. In the UK, only those deemed 60% disabled — such as losing a limb or vision — qualify for a £120,000 payout under a widely criticized government scheme.

Emerging concerns: Post-vaccination syndrome

The French case coincides with rising scrutiny of long-term post-vaccine symptoms, particularly following mRNA vaccines like Pfizer and Moderna. Researchers report conditions such as brain fog, tinnitus, and immune dysfunction under the umbrella of “post-vaccination syndrome,” though data remains preliminary.

While severe reactions like meningoencephalitis are statistically rare, this case underscores the imperative for rigorous, long-term surveillance of vaccine side effects. As global health systems balance pandemic-era urgency with individualized risk assessments, transparency and adaptive policies will be critical to maintaining public trust—especially as alternative treatments gain traction among wary populations. Bookmark Vaccines.news to your favorite independent websites for updates on experimental gene therapy injections that lead to turbo cancer, brain swelling damage and Long-Vax-Syndrome. #VaccineViolence #DirtyVaccines

Sources for this article include:

Pandemic.news

NaturalNews.com

DailyMail.co.uk